National Cancer Institute

TitleOrganizationLOI dateDue DateKeywordsFOA
Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional)National Cancer Institute11/15/202312/15/2023Early Career Investigator, Cancer Disparities, Gene Editing, Cancer Health DisparitiesRFA-CA-23-033
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)National Cancer Institute10/17/202311/17/2023Biomedical Informatics, Cancer Informatics, Health Data Management, Cancer ResearchRFA-CA-23-016
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)National Cancer Institute10/17/202311/17/2023Neuroscience, Brain Disorders, Molecular Biology, Gut-Brain AxisRFA-CA-23-015
Mechanisms of Fusion-Driven Oncogenesis in Childhood Cancers (U01 Clinical Trial Not Allowed)National Cancer Institute10/15/202311/15/2023Clinical Trials, Cancer Immunoprevention, Intramural Fellows, Comprehensive Cancer ControlRFA-CA-23-036
Next Generation Chemistry Centers for Fusion Oncoproteins (UM1 Clinical Trial Not Allowed)National Cancer Institute10/15/202311/15/2023Nanotechnology, Brain Disorders, Biomedical Systems, BiomarkersRFA-CA-23-037
Single Source: Pediatric Early Phase Clinical Trials Network (PEP-CTN; UM1 Clinical Trial Required)National Cancer Institute10/15/202311/15/2023Pediatric, Early phase clinical trials, NetworkRFA-CA-24-007
Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)National Cancer Institute9/13/202310/13/2023Health Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Community ExposuresRFA-CA-24-005
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)National Cancer Institute11/17/2023NCI, Predoctoral, Postdoctoral, Fellow Transition Award, Early StageRFA-CA-23-042
NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional)National Cancer Institute2/6/2024Health Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Cancer MoonshotRFA-CA-050
NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional)National Cancer Institute6/20/2023NCI, pilot, PAR-23-058
Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R21 Clinical Trial Not Allowed)National Cancer Institute12/15/2023Disparities, biology, Diversity, underrepresented, cancer initiation, progression, exploratory
Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R01 Clinical Trial Not Allowed)National Cancer Institute12/15/2023Disparities, biology, Diversity, underrepresented, cancer initiation, progression,
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)National Cancer Institute11/17/2023Exploratory, biology, genetics, novel interventions, Mathematics, Artifical Intelligence
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)National Cancer Institute11/17/2023Biology, genetics, novel interventions, Mathematics, Artifical Intelligence, disparities, cancer control,

Can’t find what you’re looking for? Please contact Researchadmin@cancer.ufl.edu for assistance in finding additional funding opportunities.

NCI Cancer Center badge